Sinovac

Sinovac Biotech
Interest of	Zhao Zhendong
Sponsored by	Bill & Melinda Gates Foundation

Sinovac Biotech Ltd is a biopharmaceutical company that focuses on the research, development, manufacture and commercialisation of vaccines that protect against human infectious diseases. The company is based in Beijing, China.

Sinovac's commercialised vaccines include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu (influenza), Panflu (H5N1) and PANFLU.1 (H1N1).

Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

In mid-April 2020, China approved a clinical trial for a candidate COVID-19/Vaccine developed by Sinovac.

In 2018, Sinovac received a $1,767,573 grant from the Bill & Melinda Gates Foundation for pneumonia research.

 

Sponsor

Event	Description
Bill & Melinda Gates Foundation	Very influential and rich foundation established to take leadership of global health.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.

References

This page imported content from Wikipedia on 22 May 2020.
Wikipedia is not affiliated with Wikispooks.   Original page source here